Products
Platform
Research
Market
Learn
Emcure Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 2,272.94 | 2,104.23 | 2,120.70 | 1,966.53 | 2,037.64 |
| Other Income Qtr Cr | 3.12 | 3.70 | 4.45 | 3.90 | 35.65 |
| Operating Revenues Qtr | 2,269.82 | 2,100.54 | 2,116.24 | 1,962.63 | 2,001.98 |
Loading chart... | |||||
Operating Expenses Qtr | 1,794.34 | 1,683.76 | 1,713.84 | 1,608.02 | 1,621.11 |
Operating Profit Qtr | 475.48 | 416.77 | 402.40 | 354.61 | 380.87 |
EBITDA Qtr Cr | 478.60 | 416.97 | 396.48 | 358.50 | 416.53 |
Depreciation Qtr | 104.64 | 99.46 | 96.84 | 96.81 | 96.90 |
Net Profit Qtr | 243.46 | 206.95 | 188.96 | 153.72 | 194.57 |
Basic EPS Qtr | 12.85 | 10.92 | 9.97 | 8.12 | 10.33 |
Open Demat Account
Open Demat Account